Surprisingly, CBD had not shown an affinity to CB1 or CB2 receptors but manifested anti-inflammatory characteristics in the AD animal model (Esposito et al., 2006a; Martín-Moreno et al., 2011). This evidence concerns the gene CNR1 and Alzheimer disease.